352 related articles for article (PubMed ID: 10660629)
61. Activation of p27Kip1 Expression by E2F1. A negative feedback mechanism.
Wang C; Hou X; Mohapatra S; Ma Y; Cress WD; Pledger WJ; Chen J
J Biol Chem; 2005 Apr; 280(13):12339-43. PubMed ID: 15713665
[TBL] [Abstract][Full Text] [Related]
62. An unliganded thyroid hormone beta receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis.
Furumoto H; Ying H; Chandramouli GV; Zhao L; Walker RL; Meltzer PS; Willingham MC; Cheng SY
Mol Cell Biol; 2005 Jan; 25(1):124-35. PubMed ID: 15601836
[TBL] [Abstract][Full Text] [Related]
63. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
[TBL] [Abstract][Full Text] [Related]
64. Active transcriptional repression by the Rb-E2F complex mediates G1 arrest triggered by p16INK4a, TGFbeta, and contact inhibition.
Zhang HS; Postigo AA; Dean DC
Cell; 1999 Apr; 97(1):53-61. PubMed ID: 10199402
[TBL] [Abstract][Full Text] [Related]
65. The role of p16 in the E2F-dependent thymidine kinase regulation.
Hengstschläger M; Hengstschläger-Ottnad E; Pusch O; Wawra E
Oncogene; 1996 Apr; 12(8):1635-43. PubMed ID: 8622883
[TBL] [Abstract][Full Text] [Related]
66. Activation of the murine dihydrofolate reductase promoter by E2F1. A requirement for CBP recruitment.
Fry CJ; Pearson A; Malinowski E; Bartley SM; Greenblatt J; Farnham PJ
J Biol Chem; 1999 May; 274(22):15883-91. PubMed ID: 10336493
[TBL] [Abstract][Full Text] [Related]
67. Alterations of cell cycle regulators affecting the RB pathway in nonfamilial retinoblastoma.
Orjuela M; Orlow I; Dudas M; Ponce-Castañeda MV; Ridaura C; Leal C; Salazar A; Abramson D; Gerald W; Cordon-Cardo C
Hum Pathol; 2001 May; 32(5):537-44. PubMed ID: 11381373
[TBL] [Abstract][Full Text] [Related]
68. Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers.
Jacobs JJ; Keblusek P; Robanus-Maandag E; Kristel P; Lingbeek M; Nederlof PM; van Welsem T; van de Vijver MJ; Koh EY; Daley GQ; van Lohuizen M
Nat Genet; 2000 Nov; 26(3):291-9. PubMed ID: 11062467
[TBL] [Abstract][Full Text] [Related]
69. E2F-1 but not E2F-4 can overcome p16-induced G1 cell-cycle arrest.
Mann DJ; Jones NC
Curr Biol; 1996 Apr; 6(4):474-83. PubMed ID: 8723352
[TBL] [Abstract][Full Text] [Related]
70. MyoD activity upregulates E2F1 and enhances transcription from the cyclin E promoter in differentiating myoblasts lacking a functional retinoblastoma protein.
Tedesco D; Vesco C
Exp Cell Res; 2001 Oct; 269(2):301-11. PubMed ID: 11570822
[TBL] [Abstract][Full Text] [Related]
71. Retinoblastoma (Rb) tumor-suppressor pathway alterations in meningeal hemangiopericytomas: High E2F transcription factor 1 expression and loss of Rb expression: study by double immunofluorescence staining and laser-scanning confocal microscopy.
Martinez JC; Palomino JC; Samaniego R; Sepulveda JM; Cabello A; Ricoy JR
Cancer; 2008 Jul; 113(1):166-74. PubMed ID: 18459177
[TBL] [Abstract][Full Text] [Related]
72. Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation.
Knudsen ES; Wang JY
Mol Cell Biol; 1997 Oct; 17(10):5771-83. PubMed ID: 9315635
[TBL] [Abstract][Full Text] [Related]
73. The transcription factor E2F-1 mediates the autoregulation of RB gene expression.
Shan B; Chang CY; Jones D; Lee WH
Mol Cell Biol; 1994 Jan; 14(1):299-309. PubMed ID: 8264596
[TBL] [Abstract][Full Text] [Related]
74. Disruption of Rb/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells.
Davis JN; McCabe MT; Hayward SW; Park JM; Day ML
Cancer Res; 2005 May; 65(9):3633-42. PubMed ID: 15867358
[TBL] [Abstract][Full Text] [Related]
75. Subunit composition determines E2F DNA-binding site specificity.
Tao Y; Kassatly RF; Cress WD; Horowitz JM
Mol Cell Biol; 1997 Dec; 17(12):6994-7007. PubMed ID: 9372931
[TBL] [Abstract][Full Text] [Related]
76. Activation of E2F-mediated transcription by human T-cell leukemia virus type I Tax protein in a p16(INK4A)-negative T-cell line.
Lemasson I; Thébault S; Sardet C; Devaux C; Mesnard JM
J Biol Chem; 1998 Sep; 273(36):23598-604. PubMed ID: 9722600
[TBL] [Abstract][Full Text] [Related]
77. Cooperative alterations of Rb pathway regulators in mouse primary T cell lymphomas.
Pérez de Castro IP; Malumbres M; Santos J; Pellicer A; Fernández-Piqueras J
Carcinogenesis; 1999 Sep; 20(9):1675-82. PubMed ID: 10469610
[TBL] [Abstract][Full Text] [Related]
78. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
[TBL] [Abstract][Full Text] [Related]
79. Activation of a retinoblastoma-protein-dependent pathway by sphingosine.
Dbaibo GS; Wolff RA; Obeid LM; Hannun YA
Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):453-9. PubMed ID: 7654183
[TBL] [Abstract][Full Text] [Related]
80. Ebp1, an ErbB-3 binding protein, interacts with Rb and affects Rb transcriptional regulation.
Xia X; Cheng A; Lessor T; Zhang Y; Hamburger AW
J Cell Physiol; 2001 May; 187(2):209-17. PubMed ID: 11268000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
